Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Nikes quarterly resultsan earnings beat but a revenue miss, alongside guidance for a high-single-digit revenue declinehave intensified concerns about the turnaround, particularly amid weak Greater China and Converse sales. Traders are divided: bears focus on the outlook and persistent demand problems, while bulls point to stronger margins and earnings and see value in the selloff.

Boeing engineers and technical workers ratified a new contract, easing concern about a potential strike, while traders also focused on an FAA review of the 737 MAX software issue that could delay MAX 10 certification. Reactions were broadly upbeat about the avoided labor disruption, but the regulatory review remained a source of uncertainty; the FAA has not determined whether the glitch is a safety-of-flight issue.

Cortevas seed and genetics business spun off into Vylor, mechanically reducing CTVAs share value as investors price the standalone crop-protection company. Traders are divided between viewing the selloff as an overreaction and seeing the separation as a loss of the business that drove much of Cortevas value.

Cerebras is under pressure as traders point to insider share unlocks and sales, alongside reports that OpenAIs latest Ultrafast tier is using Nvidia GPUs rather than Cerebras hardware, raising concerns about its key customer relationship. Bulls argue this does not establish that OpenAI is abandoning its multiyear commitment and continue to cite AI-inference demand, while bearish sentiment focuses on added share supply and execution risk.

Ondas defense-drone business is drawing attention around new counter-drone and government-contract developments, including the Dronebuster REACH launch and expanded DZYNE awards. Traders are split between seeing these developments and broader Pentagon interest in autonomous systems as signs of growth, and doubting the outlook as the stock stays weak amid concerns about dilution and alleged short-selling.

Shareholder approval of Evernorths merger with Armada and its planned Nasdaq listing as an XRP treasury company holding roughly 473 million XRP are driving attention. Traders are upbeat about the XRP exposure and a potentially reduced public float, while others flag SPAC volatility, dilution and uncertainty around XRPs value; warrant pricing is also a major discussion point.

FICO is rebounding after traders cited FHFA approval of its Direct Licensing Program as a way to sell scores directly to mortgage lenders. The recovery is being weighed against concerns that VantageScores inclusion in mortgage pricing grids could erode FICOs market share and pricing power.

A sharp selloff has traders speculating about a possible leak or disappointing trial data ahead of an anticipated ovarian-cancer update, while others suspect renewed ATM dilution. No specific negative development is confirmed, and the discussion reflects uncertainty about the drop.

Accentures fiscal fourth-quarter earnings beat and record annual bookings drove a sharp rally, with traders viewing strong deal flow as evidence that client demand for consulting and AI implementation remains resilient. The move has also prompted profit-taking and renewed debate over whether AI will ultimately disrupt traditional consulting despite the stronger bookings.

UMAC is drawing attention amid a sharp selloff and confusion over its cause: some traders speculatewithout confirmationthat the company may issue shares, while others point to delayed government contracts and funding. The Pentagons new autonomous-warfare initiative is also prompting debate over whether drone-sector policy news should support the stock or has already been priced in.